ADVERTISEMENT

Posttreatment survivorship care needs of Spanish-speaking Latinas with breast cancer

The Journal of Community and Supportive Oncology. 2017 January;15(1) : | 10.12788/jcso.0325
Author and Disclosure Information

Background A comprehensive assessment of Spanish-speaking breast cancer survivors’ (SSBCS) survivorship needs is lacking.

Objective Assess SSBCS’ posttreatment symptom management, psychosocial, and informational needs.

Methods 118 telephone surveys and 25 in-person semistructured interviews with SSBCS, and semistructured interviews with 5 support providers and 4 physicians who serve SSBCS from 5 Northern California counties.

Results Based on the interview and survey results, the most bothersome physical symptoms (bothered by it in the past month Somewhat/Quite a bit/A lot) were identified as: joint pain, fatigue, hot flashes, numbness in hands/feet, and vaginal dryness. The most bothersome emotional symptoms were: thoughts of recurrence/new cancers, depression/sadness, anxieties, and stress. Seven themes emerged from interviews: unmet physical symptom management needs; social support from family/friends often ends when treatment is completed; challenges resuming roles; sense of abandonment by health care system when treatment ends; need for formal transition from active treatment to follow-up care; fear of recurrence especially when obtaining follow-up care; and desire for information on late effects of initial treatments and side effects of hormonal treatments. We present a conceptual framework for survivorship care interventions for SSBCS.

Limitations Sample may not represent SSBCS’ concerns seen outside of Northern California hospitals.

Conclusions Physical and psychosocial symptoms were common among SSBCS. This population needs culturally appropriate survivorship care programs that address symptom management, psychosocial concerns, follow-up care, and healthy lifestyles.

Funding Supported by funds from the California Breast Cancer Research Grants Program Office of the University of California, grant number19AB-2500; from the National Cancer Institute, grant numbers 1U54CA153511 and 5 R25 CA13430; from the National Institute on Aging, grant number P30 AG15272; and University of California San Francisco-Clinical & Translational Science Institute, grant number UL1 TR000004 from the National Center for Advancing Translational Sciences, National Institutes of Health.

 

Accepted for publication December 22, 2016. Correspondence Anna M Nápoles, PhD, MPH; anapoles@ucsf.edu. Disclosures Dr Dixit is a consultant and advisor to Merck Sharp & Dohme Corp. All the other authors report no disclosures or conflicts of interest.

JCSO 2017;15(1):20-27
doi: https://doi.org/10.12788/jcso.0325

©2017 Frontline Medical Communications

After treatment, cancer patients transition to a survivorship phase, often with little information or support. Cancer survivors are at increased risk of recurrence, secondary cancers, comorbid conditions, and late treatment effects.1,2 However, many remain unaware of these risks and the options for managing them3 and face numerous unmet medical, psychosocial, and informational needs that can be addressed through survivorship care programs.4 Anxiety may increase as they lose their treatment team’s support while attempting to reestablish their lives.2 Patients need to know the long-term risks of cancer treatments, probabilities of recurrence and second cancers, effectiveness of surveillance and interventions for managing late effects and psychosocial concerns, and benefits of healthy lifestyles.2

Due to sociocultural and economic factors, Spanish-speaking Latina breast cancer survivors (SSBCS) suffer worse posttreatment health-related quality of life and more pain, fatigue, depressive symptoms, body image issues, and distress than their white counterparts.5-7 However, they are less likely to receive necessary cancer treatment, symptom management, and surveillance. For example, compared with whites, Latina breast cancer survivors receive less guideline-adherent treatment8 and follow-up care, including survivorship information.3,9 SSBCS, in particular have less access to survivorship information.10 Consequently, SSBCS are more likely to report unmet symptom management needs.11

Several breast cancer survivorship program trials have included Latinas,12,13 but their effectiveness has been demonstrated only for depressive symptoms or health worry. A comprehensive assessment of the posttreatment needs of SSBCS would provide a foundation for designing tailored survivorship interventions for this vulnerable group. This study aimed to identify the symptom management, psychosocial, and informational needs of SSBCS during the transition to survivorship from the perspectives of SSBCS and their cancer support providers and cancer physicians.

Methods

We sampled respondents within a 5-county area in Northern California to obtain multiple perspectives of the survivorship care needs of SSBCS using structured and in-depth methods: a telephone survey of SSBCS; semistructured interviews with SSBCS; semistructured interviews with cancer support providers serving SSBCS; and semistructured interviews with physicians providing cancer care for SSBCS. The study protocol was approved by the University of California San Francisco Committee on Human Research.

Sample and procedures

Structured telephone survey with SSBCS. The sample was drawn evenly from San Francisco General Hospital-University of California San Francisco primary care practices and SSBCS from a previous study who agreed to be re-contacted.14 The inclusion criteria were: completed active treatment (except adjuvant hormonal therapy) for nonmetastatic breast cancer within 10 years; living in one of the five counties; primarily Spanish-speaking; and self-identified as Latina. The exclusion criteria were: previous cancer except nonmelanoma skin cancer; terminal illness; or metastatic breast cancer. Study staff mailed potential participants a bilingual letter and information sheet, and bilingual opt-out postcard (6th grade reading level assessed by Flesch-Kincaid grade level statistic). Female bilingual-bicultural research associates conducted interviews of 20-30 minutes in Spanish after obtaining verbal consent. Participants were mailed $20. Surveys were conducted during March-November 2014.

Semistructured in-person interviews with SSBCS. Four community-based organizations (CBOs) in the targeted area providing cancer support services to Latinos agreed to recruit SSBCS for interviews. Inclusion criteria were identical to the survey. Patient navigators or support providers from CBOs contacted women by phone or in-person to invite them to an interview to assess their cancer survivorship needs. Women could choose a focus group or individual interview. With permission, names and contact information were given to study interviewers who called, explained the study, screened for eligibility, and scheduled an interview.

Recruitment was stratified by age (under or over age 50). We sampled women until saturation was achieved (no new themes emerged). Focus groups (90 minutes) were conducted at the CBOs. Individual interviews (45 minutes) were conducted in participants’ homes. Written informed consent was obtained. Participants were paid $50. Interviews were conducted during August-November, 2014, audiotaped, and transcribed.

Semistructured in-person interviews with cancer support providers and physicians. Investigators invited five cancer support providers (three patient navigators from three county hospitals, and two CBO directors of cancer psychosocial support services) and four physicians (three oncologists and one breast cancer surgeon from three county hospitals) to an in-person interview to identify SSBCS’ survivorship care needs. All agreed to participate. No further candidates were approached because saturation was achieved. We obtained written informed consent and 30-minute interviews were conducted in participants’ offices during August-October, 2014. Interviews were audiotaped and transcribed. Participants were paid $50.

Ethical approval. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent. Informed consent was obtained from all individual participants included in the study.